Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors
It can protect the skin, repair DNA, and can assist with reducing signs of ageing
The mean age was 44.05 years, with 30.47% male
NNMT-mediated CD44 mRNA m6A methylation produces a CD44v3 splice variant, while MNA stabilizes CD44 protein by inhibiting the ubiquitin-mediated degradation
US$ 26.50
US$ 29.86
US$ 26.79
US$ 23.23
US$ 27.17
US$ 25.90
US$ 26.25
US$ 22.61
US$ 23.58
US$ 21.46
US$ 21.85
